Imaging has emerged as one of the key tools used by biomedical investigators to further our understanding of human biology in health and disease. XNAT has emerged as the most widely used imaging informatics for supporting this research. We will develop the next generation of XNAT technology to support the ongoing evolution of imaging research. Development will focus on four key use cases: institutional repositories, clinical imaging research, multi-center trials, and data sharing. A variety of new capabilities wil be implemented, including deeper integration with clinical information systems, scalability services including integration with the cloud, on- demand access to statistical and other computational platforms, a GUI-based form building interface, configurable data feeds, and quality assurance and communications tools. These capabilities will be developed and evaluated in the context of real world scientific programs. A number of outreach and support activities targeted at XNAT users and developers.
Medical imaging is one of the key methods used by biomedical researchers to study human biology in health and disease. The imaging informatics platform described in this application will enable biomedical researchers to capture, analyze, and share imaging and related data. These capabilities address key bottlenecks in the pathway to discovering cures to complex diseases such as Alzheimer's disease, cancer, and heart disease.
|Lee, Megan H; Miller-Thomas, Michelle M; Benzinger, Tammie L et al. (2016) Clinical Resting-state fMRI in the Preoperative Setting: Are We Ready for Prime Time? Top Magn Reson Imaging 25:11-8|
|Babulal, Ganesh M; Ghoshal, Nupur; Head, Denise et al. (2016) Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Am J Geriatr Psychiatry 24:1095-1104|
|Soosman, Steffan K; Joseph-Mathurin, Nelly; Braskie, Meredith N et al. (2016) Widespread white matter and conduction defects in PSEN1-related spastic paraparesis. Neurobiol Aging 47:201-209|
|Lim, Yen Ying; Hassenstab, Jason; Cruchaga, Carlos et al. (2016) BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain 139:2766-2777|
|Vos, Stephanie J B; Gordon, Brian A; Su, Yi et al. (2016) NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Neurobiol Aging 44:1-8|
|Hodge, Michael R; Horton, William; Brown, Timothy et al. (2016) ConnectomeDB--Sharing human brain connectivity data. Neuroimage 124:1102-7|
|Herrick, Rick; Horton, William; Olsen, Timothy et al. (2016) XNAT Central: Open sourcing imaging research data. Neuroimage 124:1093-6|
|Kogan, Alex; Alpert, Kathryn; Ambite, Jose Luis et al. (2016) Northwestern University schizophrenia data sharing for SchizConnect: A longitudinal dataset for large-scale integration. Neuroimage 124:1196-201|
|Gordon, Brian A; Blazey, Tyler; Su, Yi et al. (2016) Longitudinal Î²-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol 73:1192-1200|
|Fouke, Sarah Jost; Benzinger, Tammie L; Milchenko, Mikhail et al. (2014) The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers. Neurosurgery 74:88-98|
Showing the most recent 10 out of 18 publications